These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37217263)

  • 1. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study.
    Tangri N; Moriyama T; Schneider MP; Virgitti JB; De Nicola L; Arnold M; Barone S; Peach E; Wittbrodt E; Chen H; Järbrink K; Kushner P
    BMJ Open; 2023 May; 13(5):e067386. PubMed ID: 37217263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study.
    Tangri N; Peach EJ; Franzén S; Barone S; Kushner PR
    Adv Ther; 2023 Jun; 40(6):2869-2885. PubMed ID: 37133647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undiagnosed and untreated chronic kidney disease and its impact on renal outcomes in the Japanese middle-aged general population.
    Yamada Y; Ikenoue T; Saito Y; Fukuma S
    J Epidemiol Community Health; 2019 Dec; 73(12):1122-1127. PubMed ID: 31563895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study.
    Kushner P; Peach E; Wittbrodt E; Barone S; Chen H; Sanchez JJG; Järbrink K; Arnold M; Tangri N
    Clin Kidney J; 2022 Apr; 15(4):738-746. PubMed ID: 35371463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of under-registration of chronic kidney disease stages 3-5 in Belgian general practices using logistic regression.
    Van den Wyngaert I; Mamouris P; Vaes B; Van Pottelbergh G
    PLoS One; 2022; 17(12):e0279291. PubMed ID: 36548280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease in Russia: the Ural eye and medical study.
    Bikbov MM; Zainullin RM; Kazakbaeva GM; Gilmanshin TR; Rakhimova EM; Rusakova IA; Bolshakova NI; Safiullina KR; Panda-Jonas S; Yakupova DF; Nikitin NA; Jonas JB
    BMC Nephrol; 2020 May; 21(1):198. PubMed ID: 32450794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD.
    Tangri N; Alvarez CS; Arnold M; Barone S; Cebrián A; Chen H; De Nicola L; Järbrink K; Kanumilli N; Lim KS; Moriyama T; Pecoits Filho R; Ribeiro de Castro MC; Santamaria R; Schneider MP; Virgitti JB; Kushner P
    Eur J Clin Invest; 2024 Nov; 54(11):e14282. PubMed ID: 39023418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
    Mitchell T; Hadlow N; Chakera A
    Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.
    Gosmanova EO; Chen K; Rejnmark L; Mu F; Swallow E; Briggs A; Ayodele O; Sherry N; Ketteler M
    Adv Ther; 2021 Apr; 38(4):1876-1888. PubMed ID: 33687651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.
    Cepoi V; Onofriescu M; Segall L; Covic A
    Int Urol Nephrol; 2012 Feb; 44(1):213-20. PubMed ID: 21360160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study.
    Hirst JA; Hill N; O'Callaghan CA; Lasserson D; McManus RJ; Ogburn E; Mena JMO; Shine B; Taylor CJ; Vazquez-Montes MD; Yang Y; Hobbs FR
    Br J Gen Pract; 2020 Apr; 70(693):e285-e293. PubMed ID: 32041766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
    Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
    Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population characteristics and diagnosis rate of chronic kidney disease by eGFR and proteinuria in Japanese clinical practice: an observational database study.
    Tanaka T; Maruyama S; Chishima N; Akiyama H; Shimamoto K; Inokuchi S; Yokota K; Ozaki A
    Sci Rep; 2024 Mar; 14(1):5172. PubMed ID: 38431648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.